The sales of calcium supplement in Western Europe are set to advance at a CAGR of 7.2% from 2023 to 2033. The Western Europe calcium supplement industry is likely to attain a worth of USD 1,826.8 million by 2033, up from USD 914.9 million in 2023.
The future looks very promising for calcium supplement sales in Western Europe as people have become more health-conscious and take proactive measures to live a healthy lifestyle. For optimal bone health, calcium supplements are gaining popularity. Hence, there is going to be a rise in demand for calcium supplement in Western Europe due to a growing understanding of the scientific basis for the body's requirement for sufficient calcium and its benefits in maintaining a healthy heart, muscles, and nerves.
Attributes | Details |
---|---|
Demand Analysis (2023) | USD 914.9 million |
Demand Forecast (2033) | USD 1,826.8 million |
CAGR Estimation (2023 to 2033) | 7.2% |
Insights into the Growth Drivers of Calcium Supplement Industry in Western Europe
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
A thorough segmentation analysis of calcium supplements in Western Europe is given in this section. Manufacturers of calcium supplement in Western Europe closely monitor consumer trends, particularly the rising demand for soft gel pills. The men's segment is especially noteworthy within the end use category, indicating a significant market dynamic.
Segment | Men |
---|---|
Industry Share in 2023 | 47.6% |
Segment | Soft Gel Pills |
---|---|
Industry Share in 2023 | 54.3% |
The following table exhibits the expected market share for calcium supplements in Western Europe, emphasizing significant economies such as the United Kingdom, France, Italy, Germany, and Spain. It is clear from a thorough descriptive analysis that the United Kingdom has a bright future, especially because the nation is home to several significant producers of calcium supplements.
Countries | Value CAGR from 2023 to 2033 |
---|---|
United Kingdom | 8.4% |
Germany | 8.0% |
France | 7.4% |
Italy | 6.9% |
Netherlands | 6.5% |
Intense competition among leading vendors in the Western European calcium supplement industry is a result of their efforts to satisfy the rising demand from consumers for bone health solutions. Prominent calcium supplement companies participate in strategic initiatives like partnerships, marketing campaigns, and product innovation to obtain a competitive edge.
The competitive landscape is dynamic due to the presence of established pharmaceutical and nutrition companies, and the evolving preferences of consumers toward preventive healthcare.
Key Breakthroughs in Calcium Supplement in Western Europe
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Attribute | Details |
---|---|
Estimated Valuation (2023) | USD 914.9 million |
Projected Valuation (2033) | USD 1,826.8 million |
Anticipated CAGR (2023 to 2033) | 7.2% |
Historical Analysis of Calcium Supplement in Western Europe | 2018 to 2022 |
Demand Forecast for Calcium Supplement in Western Europe | 2023 to 2033 |
Quantitative Units | Revenue in USD million and CAGR from 2023 to 2033 |
Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
Key Countries Analyzed while Studying Opportunities in Calcium Supplement in Western Europe | United Kingdom, Germany, France, Italy, Spain |
Key Companies Profiled in the Industry Analysis of Calcium Supplement in Western Europe | Nature Made; By-health Co.,Ltd.; Harbin Pharmaceutical Group; Bayer AG; GlaxoSmithKline (GSK); GNC Holdings Inc.; Bio Island; Nature Bounty; High Change; Bluebonnet Nutrition; Pfizer (Caltrate); A&Z Pharmaceutical; Amway (Nutrilite); Shanxi Zhendong Pharmaceutical Co., Ltd.; BioCalth |
The sales of calcium supplement in Western Europe were valued at USD 858.7 million in 2022.
The market value of calcium supplement in Western Europe is set to reach USD 914.9 million in 2023.
The demand for calcium supplement in Western Europe is anticipated to rise at 7.2% CAGR from 2023 to 2033.
The Western Europe market size for calcium supplement is likely to surpass USD 1,826.8 million by 2033.
The men segment is expected to dominate the calcium supplement industry with a share of 47.6% in 2023.
The HCAGR of sales of calcium supplement in Western Europe was 4.9% between 2018 and 2022.
1. Executive Summary 2. Market Overview 3. Market Background 4. Industry Analysis and Outlook 2018 to 2022 and Forecast, 2023 to 2033 5. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Type 5.1. Gummy 5.2. Pill 5.3. Capsule 5.4. Liquid 5.5. Others 6. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Product 6.1. Calcium Carbonate 6.2. Calcium Gluconate 6.3. Calcium Citrate 6.4. Calcium Lactate 6.5. Calcium Phosphate 6.6. Calcium Orotate 7. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Applications 7.1. Adult 7.2. Children 8. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. UK 8.2. Germany 8.3. Italy 8.4. France 8.5. Spain 8.6. Rest of 9. UK Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 10. Germany Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 11. Italy Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 12. France Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 13. Spain Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 14. Rest of Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033 15. Market Structure Analysis 16. Competition Analysis 16.1. Tetra Chemicals Europe 16.2. Pharma Manufacture 16.3. Bayer AG 16.4. AandZ Pharmaceutical 16.5. GSK 16.6. Bio Island 16.7. Nature Made 16.8. By-health Co., Ltd. 16.9. Harbin Pharmaceutical Group 16.10. Bayer AG 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Food and Beverage Insights
View Reports